Works matching IS 11738804 AND DT 2023 AND VI 37 AND IP 6

Results: 10

Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 843, doi. 10.1007/s40259-023-00621-6
By:
- Tsao, Yu-Chien;
- Chen, Ting-Ying;
- Wang, Li-An;
- Lee, Chia-Chun;
- Lee, Wan-Ju Annabelle;
- Hsu, Sheng-Min;
- Lai, Chi-Chun;
- Shao, Shih-Chieh;
- Hung, Jia-Horung;
- Lai, Edward Chia-Cheng
Publication type:
Article
Patients' Perceptions of Biosimilars: A Systematic Review.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 829, doi. 10.1007/s40259-023-00620-7
By:
- Wu, Qiyou;
- Wang, Zhitao;
- Wang, Xin;
- Yu, Hui;
- Sun, Jing
Publication type:
Article
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 891, doi. 10.1007/s40259-023-00624-3
By:
- Pham, Catherine;
- Niu, Fang;
- Delate, Thomas;
- Buchschacher Jr, Gary L.;
- Li, Yan;
- Ekinci, Ekim;
- Le, Kim;
- Hui, Rita L.
Publication type:
Article
Malaria Vaccines: Progress to Date.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 737, doi. 10.1007/s40259-023-00623-4
By:
- Stanisic, Danielle I.;
- Good, Michael F.
Publication type:
Article
Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 793, doi. 10.1007/s40259-023-00622-5
By:
- Miranda, Javiera;
- Lefin, Nicolás;
- Beltran, Jorge F.;
- Belén, Lisandra Herrera;
- Tsipa, Argyro;
- Farias, Jorge G.;
- Zamorano, Mauricio
Publication type:
Article
Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 855, doi. 10.1007/s40259-023-00631-4
By:
- Kirsch-Stefan, Nadine;
- Guillen, Elena;
- Ekman, Niklas;
- Barry, Sean;
- Knippel, Verena;
- Killalea, Sheila;
- Weise, Martina;
- Wolff-Holz, Elena
Publication type:
Article
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 873, doi. 10.1007/s40259-023-00616-3
By:
- Müller-Ladner, Ulf;
- Dignass, Axel;
- Gaffney, Karl;
- Jadon, Deepak;
- Matucci-Cerinic, Marco;
- Lobaton, Triana;
- Carron, Philippe;
- Gisbert, Javier P.;
- Pande, Ira;
- Utzinger, Maximilian;
- Addison, Janet
Publication type:
Article
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 757, doi. 10.1007/s40259-023-00617-2
By:
- Berry, Parul;
- Khanna, Sahil
Publication type:
Article
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 775, doi. 10.1007/s40259-023-00614-5
By:
- Sanber, Khaled;
- Rosner, Samuel;
- Forde, Patrick M.;
- Marrone, Kristen A.
Publication type:
Article
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.
Published in:
BioDrugs, 2023, v. 37, n. 6, p. 813, doi. 10.1007/s40259-023-00613-6
By:
- Batu, Ezgi Deniz;
- Sener, Seher;
- Cam, Veysel;
- Aktay Ayaz, Nuray;
- Ozen, Seza
Publication type:
Article